- About Us
- Advertise
- Contact Us
- Editorial Info
- Editorial Advisory Board
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2025 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Pharmaceutical Technology-02-02-2013
Pharmaceutical Technology
Q&A With Chris Ecles
February 02, 2013
Industry Leaders
37
2
PharmTech speaks to Chris Eccles, managing director of ChargePoint Technology.
Seeking Cold Chain Efficiency
February 02, 2013
Cover Story
37
2
Medication safety and efficacy depend on maintaining products at the proper temperature.
The EU's Falsified Medicines Directive and APIs
February 02, 2013
Ask the Expert
37
2
Siegfried Schmitt, a principal consultant with PAREXEL, discusses how the EU's Falsified Medicines Directive will affect US API production.
End of the Dedicated CMO?
February 02, 2013
Outsourcing Outlook
37
2
Is the contract-only CMO an endangered species?
Offering a Pharma View of Social Media
February 02, 2013
Guest Editorial
37
2
Why social media presents unique challenges and opportunities for pharmaceutical companies.
Tracking Growth in Biologics
February 02, 2013
BioForum
37
2
The share of biologic-based drugs in the global pharmaceutical market is on the rise.
Report from India
February 02, 2013
Global Feature
37
2
Quality assurance of biological products is central to India's good distribution practices guidelines.
Rouge Contaminants and Water Systems
February 02, 2013
CMC Troubleshooting
37
2
Measuring the rouge corrosion rate can help determine when a system should be cleaned so the final product is not impacted
Pharma Conversation & Community
February 02, 2013
News
37
2
A round up of news from across the web, including trends from social social media platforms.
GMP Compliance Becomes Prominent Enforcement Issue
February 02, 2013
Regulation & Compliance
37
2
Prosecutors and regulators challenge manufacturing quality failings likely to cause patient harm.
Calculating the Reportable Result from Retest Data
February 02, 2013
Statistical Solutions
37
2
Two methods to evaluate retest data following out-of-specification results.
The Human Error Behind Human Error
February 02, 2013
Insider Solutions
37
2
A thorough investigation of all possible causes of deviations should be performed.
Navigating Emerging Markets — Eastern Europe
February 02, 2013
Global Feature
37
2
Eastern Europe is moving towards a goal of harmonized regulations.
Determination of Surface Visible Residue Limits on Pharmaceutical Plant Equipment
February 02, 2013
Peer-Reviewed Research
37
2
The minimum amount of residue that can be visually detected is demonstrated for a small number of active pharmaceutical ingredients (APIs) on a range of different surface materials.
Modernization of USP Standards
February 02, 2013
Inside USP
37
2
The US Pharmacopeial Convention contiues to make modernization of standards a top priority in 2013.
Regulatory Roundup
February 02, 2013
Regulation & Compliance
37
2
A roundup of regulatory news from across the global pharmaceutical industry.
The Latest in Tableting and Granulation
February 02, 2013
Product Spotlight
37
2
New product reviews for February 2013.
Solving Tableting and Tooling Problems
February 02, 2013
Troubleshooting
37
2
Adopting a seven-step process to maintenance and storage improves tableting quality.
Anticounterfeiting Technologies: Tools to Combat Counterfeiters
February 02, 2013
37
2
Protecting patients from counterfeit medicines is a pressing issue facing governments and the pharmaceutical industry.
Improving Inhaled Product Testing: Methods for Obtaining Better In vitro-In vivo Relationships
February 02, 2013
Peer-Reviewed Research
37
2
Even in an industry in which all product development is complicated by the intricacies of human biology, orally inhaled products (OIP) stand out as singularly demanding.
Gaining Stereoselectivity in Asymmetric Synthesis
February 02, 2013
API Synthesis & Manufacturing
37
2
Researchers use inorganic catalysts as an alternative to biocatalysts in the selective conversion of sugars to produce chiral building blocks.
Modernization of the Standards for Elemental Impurities
February 02, 2013
Position Paper
37
2
Recent activity in standards-setting organizations has raised interest in the impact of testing for impurities that may enter the product before it is mined or harvested or even due to intentional use of some reagents.
Pharmaceutical Technology, February 2013 Issue (PDF)
February 02, 2013
Issue PDF
37
2
Seeking Cold-Chain Efficiency